Eleven of the 22 analysed CpGs in the genes PDE4C, ELOVL2 and RPA2 exhibited significant differences between young, healthy individuals and age- and sex-matched individuals with growth disorders. This evidence concerns the gene ELOVL2 and hereditary endocrine growth disease.